Role of Peripheral Vision in Scene Perception (PERISCE)
PERISCE
1 other identifier
observational
120
0 countries
N/A
Brief Summary
Despite its low spatial resolution, peripheral vision is very useful for rapidly categorizing a visual scene. Low spatial frequencies of a visual stimulus available in peripheral vision would allow a coarse categorization of the scene and objects (deciding, for example, whether it is an urban or natural landscape). This first representation would then trigger predictive mechanisms which would subsequently guide a more detailed visual analysis in central vision. The psychophysical studies that the investigators have already conducted in this scientific context has been carried out under normal vision conditions. The objective of this project is to study the influence of peripheral vision on central vision with an original approach: What are the consequences of a loss of peripheral vision on the processing performed in central vision? The project will concern patients with glaucoma. This ophthalmic pathology particularly affects the peripheral retina and thus represents a good pathological cognitive model of a visual recognition system in which peripheral vision is less important. The investigators will conduct psychophysical studies with glaucomatous patients and healthy volunteers with normal vision. All participants will be required to perform a short experiment on a computer (15 minutes) where they will look at different photographs of scenes of different luminance and spatial frequencies. Participants will have to perform various tasks on these images using the keys on the keyboard.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2022
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2022
CompletedFirst Posted
Study publicly available on registry
September 14, 2022
CompletedStudy Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
September 14, 2022
August 1, 2022
3.8 years
August 23, 2022
September 13, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Psychophysical measure : Percentage of correct response
Measure calculated by the comparison between the expected response and the response provided by the participant for each trial of the experiment
Through study completion of 45 months
Psychophysical measure : Mean reaction time in milliseconds
Measure calculated by averaging the time in milliseconds taken by the participant to provide the response for each trial of the experiment
Through study completion of 45 months
Study Arms (2)
Primary open-angle glaucoma (POAG) group
Age-matched normally sighted control group
Interventions
All participants will be required to perform a short experiment on a computer (15 minutes) where they will look at different photographs of scenes of different luminance and spatial frequencies. They will have to perform various tasks on these images using the keys on the keyboard.
Eligibility Criteria
POAG patients and age-matched normally sighted controls
You may qualify if:
- For patients :
- between 18 and 80 years old
- stable bilateral primary open angle glaucoma (POAG)
- visual acuity \> 5/10 for distant vision for the eye tested
- peripheral visual field defect on the eye tested measured through a Humphrey Visual Field Analyzer
- For healthy volunteers :
- between 18 and 80 years old
- visual acuity \> 5/10
- absence of ophthalmologic disease other than Glaucoma (age-related macular degeneration, cataract except for uncomplicated cataract surgery, amblyopia, optic neuropathy, diabetic retinopathy …)
You may not qualify if:
- ophthalmologic disease other than Glaucoma (age-related macular degeneration, cataract except for uncomplicated cataract surgery, amblyopia, optic neuropathy, diabetic retinopathy …)
- treated with medication that might compromise sustained attention (benzodiazepine, narcoleptics)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Roux-Sibilon A, Rutge F, Aptel F, Attye A, Guyader N, Boucart M, Chiquet C, Peyrin C. Scene and human face recognition in the central vision of patients with glaucoma. PLoS One. 2018 Feb 26;13(2):e0193465. doi: 10.1371/journal.pone.0193465. eCollection 2018.
PMID: 29481572BACKGROUNDRoux-Sibilon A, Trouilloud A, Kauffmann L, Guyader N, Mermillod M, Peyrin C. Influence of peripheral vision on object categorization in central vision. J Vis. 2019 Dec 2;19(14):7. doi: 10.1167/19.14.7.
PMID: 31826252BACKGROUNDPeyrin C, Roux-Sibilon A, Trouilloud A, Khazaz S, Joly M, Pichat C, Boucart M, Krainik A, Kauffmann L. Semantic and Physical Properties of Peripheral Vision Are Used for Scene Categorization in Central Vision. J Cogn Neurosci. 2021 Feb 11:1-15. doi: 10.1162/jocn_a_01689. Online ahead of print.
PMID: 33571079BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2022
First Posted
September 14, 2022
Study Start
October 1, 2022
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2027
Last Updated
September 14, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will become available after publications with no limit time
- Access Criteria
- Link to the Open Science Framework
Anonymized individual participant data will be share in the context of publications through the Open Science Framework, a tool that promotes open, centralized workflows.